Barclays
CHTP

Barclays’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

Barclays’s Portfolio CHTP Stock Details CHTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-95,900
Closed -$480K – 8041
2014
Q1 		$480K Buy
95,900
+68,900
+255% +$346K ﹤0.01% 3997
2013
Q4 		$108K Buy
27,000
+6,700
+33% +$22.6K ﹤0.01% 5587
2013
Q3 		$41K Buy
+20,300
New +$58.3K ﹤0.01% 6177

Other funds holding CHTP

Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Barclays's CHTP Position: Q2 2014 in Review

Barclays sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q2 2014, closing a stake of 101,475 shares — an estimated $508K sold.

Barclays first reported a position in CHTP in Q2 2013 and held it in 4 quarters. The position peaked at $590K in Q4 2013. 6 funds tracked by Wall St. Rank hold CHTP as of Q2 2014.

  • Barclays reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q2 2014 after selling out during the quarter.
  • Barclays sold 101,475 CHELSEA THERAPEUTICS INT'L LTD shares in Q2 2014, an estimated $508K.
  • Barclays first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q2 2013 and held it in 4 quarters.
  • Barclays's CHELSEA THERAPEUTICS INT'L LTD position peaked at $590K in Q4 2013.
  • 6 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q2 2014.

Based on Barclays's 13F filing for Q2 2014, filed 14 Aug 2014.